Clinical Trial Update: Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic ablative radiotherapy combined with immunotherapy for oligometastatic extracranial melanoma; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Melanoma Institute Australia | Conditions: Melanoma Metastatic | Phase 2 | Status: RECRUITING